T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Amazon
AMZN
|
$968M |
| 2 |
Starbucks
SBUX
|
$909M |
| 3 |
Hilton Worldwide
HLT
|
$698M |
| 4 |
NiSource
NI
|
$674M |
| 5 |
Becton Dickinson
BDX
|
$621M |
Top Sells
| 1 |
Fortive
FTV
|
$1.08B |
| 2 |
Marvell Technology
MRVL
|
$1.06B |
| 3 |
Thermo Fisher Scientific
TMO
|
$767M |
| 4 |
McKesson
MCK
|
$766M |
| 5 |
Broadcom
AVGO
|
$764M |
Sector Composition
| 1 | Technology | 29.18% |
| 2 | Healthcare | 18.36% |
| 3 | Consumer Discretionary | 13.25% |
| 4 | Industrials | 10.53% |
| 5 | Financials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Pebblebrook Hotel Trust
PEB
$1.31B
| $102M | 0.06% |
10,223,298
+3,415,696
| +50% | +$34.1M |
|
277
West Pharmaceutical
WST
$17.5B
| $102M | 0.06% |
466,434
+4,361
| +0.9% | +$954K |
|
278
Sotera Health
SHC
$4.59B
| $101M | 0.06% |
9,053,465
+1,007,963
| +13% | +$11.2M |
|
279
Preferred Bank
PFBC
$1.16B
| $99.6M | 0.06% |
1,150,614
+1,630
| +0.1% | +$141K |
|
280
Onto Innovation
ONTO
$5.09B
| $99.4M | 0.06% |
984,457
+969,112
| +6,315% | +$97.8M |
|
|
JBTM
281
JBT Marel Corporation
JBTM
$7.39B
| $99.1M | 0.06% |
823,992
+308,919
| +60% | +$37.2M |
|
282
SBA Communications
SBAC
$21.7B
| $99.1M | 0.06% |
421,822
+19,585
| +5% | +$4.6M |
|
283
Immatics
IMTX
$649M
| $98.6M | 0.06% |
18,328,455
+3,651,452
| +25% | +$19.6M |
|
284
Graco
GGG
$14B
| $97M | 0.06% |
1,128,225
+583,414
| +107% | +$50.2M |
|
285
Frontdoor
FTDR
$4.51B
| $96.6M | 0.06% |
+1,639,288
| New | +$96.6M |
|
286
Johnson & Johnson
JNJ
$429B
| $95.8M | 0.06% |
626,990
+9,166
| +1% | +$1.4M |
|
287
GeneDx Holdings
WGS
$3.68B
| $95.7M | 0.06% |
1,037,116
+533,383
| +106% | +$49.2M |
|
288
Southwest Gas
SWX
$5.68B
| $92.8M | 0.06% |
+1,246,980
| New | +$92.8M |
|
289
Renasant Corp
RNST
$3.68B
| $92M | 0.06% |
+2,561,406
| New | +$92M |
|
290
BioLife Solutions
BLFS
$1.21B
| $91.5M | 0.06% |
4,246,706
+2,898,698
| +215% | +$62.4M |
|
291
JPMorgan Chase
JPM
$824B
| $91.3M | 0.06% |
314,819
+29,457
| +10% | +$8.54M |
|
292
Stevanato
STVN
$6.18B
| $91.3M | 0.06% |
3,735,407
-9,307
| -0.2% | -$227K |
|
|
ETOR
293
eToro Group Ltd. Class A Common Shares
ETOR
$3.91B
| $90M | 0.06% |
+1,351,228
| New | +$90M |
|
294
Walker & Dunlop
WD
$2.83B
| $89.4M | 0.06% |
1,268,373
+49,492
| +4% | +$3.49M |
|
295
WEC Energy
WEC
$34.1B
| $89.4M | 0.06% |
857,870
+148,661
| +21% | +$15.5M |
|
296
Exelon
EXC
$43.8B
| $89M | 0.06% |
2,049,868
+11,329
| +0.6% | +$492K |
|
|
NTST
297
NETSTREIT Corp
NTST
$1.71B
| $88.6M | 0.06% |
5,235,991
-1,485,977
| -22% | -$25.2M |
|
298
Procept Biorobotics
PRCT
$2.2B
| $88M | 0.06% |
1,527,827
+112,424
| +8% | +$6.48M |
|
299
i3 Verticals
IIIV
$731M
| $87.3M | 0.06% |
3,175,905
+2,769,829
| +682% | +$76.1M |
|
300
Littelfuse
LFUS
$6.33B
| $87.3M | 0.06% |
384,849
-375,941
| -49% | -$85.2M |
|